FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics, gynecology, immunology and molecular biology. Method of the postpartum endometritis (PE) likelihood assessing is characterized by, that in the contents of lochias the mRNA genes expression levels are determined TNF, CD45, CD69, CD 166, as well as indices of mRNA genes expression levels ratios , and , calculating the inflammatory index (II) value according to the formula: II=1/(1+e-z)*100 %, where z is the classifying function value, calculating by the formula: , if the inflammatory index value is more than 51 %, making a conclusion on the high probability of postpartum endometritis development, with an inflammation index of ≤ 51 %, concluding that there is no postpartum endometritis.
EFFECT: invention can be used to optimize diagnosis in the diagnostics of "postpartum endometritis".
1 cl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
FORECASTING METHOD OF PUERPERAL ENDOMETRITIS DEVELOPMENT | 2020 |
|
RU2744680C1 |
EARLY DIAGNOSTIC TECHNIQUE IN POSTPARTUM ENDOMETRITIS | 2011 |
|
RU2477861C1 |
METHOD FOR POST-DELIVERY ENDOMETRITIS PREDICTION BY ALBUMIN DETOXICATION EFFICIENCY INDICATOR | 2017 |
|
RU2641028C1 |
METHOD OF DIAGNOSING SUBCLINICAL FORM OF POST-DELIVERY ENDOMETRITIS | 2007 |
|
RU2351933C2 |
METHOD FOR LOCAL TREATMENT OF POSTPARTUM ENDOMETRITIS | 2015 |
|
RU2634471C2 |
METHOD FOR CHRONIC ENDOMETRITIS DIAGNOSTICS AT MEDIUM STAGE OF SECRECTION PHASE | 2017 |
|
RU2642621C1 |
METHOD FOR DETECTING VAGINITIS IN FEMALES OF REPRODUCTIVE AGE BY EXPRESSION LEVEL OF mRNA OF CYTOKINE GENES IN VAGINAL SMEARS | 2013 |
|
RU2552310C2 |
METHOD OF TREATMENT OF PUERPERAL ENDOMETRITES | 1996 |
|
RU2135192C1 |
METHOD FOR EARLY PREDICTION OF HABITUAL MISCARRIAGE | 2014 |
|
RU2592204C1 |
METHOD FOR TREATING PUERPERAL ENDOMETRITIS CASES | 2004 |
|
RU2267327C1 |
Authors
Dates
2018-02-02—Published
2017-01-17—Filed